More Cynata Therapeutics Limited news
Cynata Therapeutics LimitedASX: CYP

Cynata Commences DFU Clinical Trial

Dec 21, 2021 at 10:04 PM EST · Issued by Cynata Therapeutics Limited

Filed with ASX · Dec 21, 2021 at 10:04 PM EST

On 6ix: 6ix.com/news/cynata-commences-dfu-clinical-trial

Cynata Therapeutics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Cynata Therapeutics Limited on 6ix

Story so far

  • Site Initiation Visit Completed for CYP DFU Clinical TrialNov 18, 2021

Earlier from Cynata Therapeutics

  • Site Initiation Visit Completed for CYP DFU Clinical TrialNov 17, 2021
  • Cynata Receives US$5m Fujifilm FeeOct 17, 2021
  • DSMB Recommends Continuation of Cynatas MEND TrialOct 7, 2021
  • Cynata Enters into a New Strategic Partnership with FujifilmSep 30, 2021
  • Further Patents for Cynata Unique Cymerus TechnologySep 15, 2021

Later from Cynata Therapeutics

  • FUJIFILM Cellular Dynamics Executes Manufacturing AgreementDec 28, 2021
  • Cynata Receives Decision to Grant a Patent in JapanJan 26, 2022
  • Notice of Allowance for Cynata Chinese PatentFeb 27, 2022
  • FDA Clears Cynata IND for Phase 2 Trial in GvHDMay 26, 2022
  • Further data supports potency of Cynata MSCsJun 13, 2022
All Cynata Therapeutics news releases↗

Follow Cynata Therapeutics into a list and get an email when it puts out news.

Follow Cynata Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer